Multiple Patients Dosed in Topical Phase I/II Clinical Trial
Highlights:
• Multiple Patients Dosed in Phase I/II clinical trial, an important human clinical
milestone
• No adverse symptoms reported - R327 well stocked in hospital pharmacy for further
patient utilisation
• Interim data readouts expected this quarter with full data end CY Q4 2021
No adverse symptoms reported !!!!
Go RECCE!!!
Ann: Multiple Patients Dosed in Topical Phase I/II Clinical Trial, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.010(3.33%) |
Mkt cap ! $84.34M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 29.5¢ | 29.0¢ | $33.79K | 116.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 135000 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 9548 | 3 |
View Market Depth
| Last trade - 11.57am 23/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |